Viatronix receives FDA clearance for 3D imaging module

Diagnostic 3D imaging software provider Viatronix Inc. received FDA 510(k) clearance for its v3D-Vascular module.

 Streamlining vascular CT, MR and 3D reconstructed x-ray angiography examinations, the module allows radiologists to examine vessels in 2D and 3D, fly through, view hard and soft plaque and make precise measurements.

 Viatronix designed the 3D-Vascular module to ease the burden placed on radiologists and technologists to create clear visualizations of complex vascular anatomy.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.